Important Safety Information and Indications
LEVOXYL is indicated for hypothyroidism—as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. Specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.
LEVOXYL is indicated for pituitary TSH suppression—in the treatment or prevention of various types of euthyroid goiters including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis) multinodular goiter and as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
Available in 11 Different Dosage Strengths:
- LEVOXYL is available in 11 different strengths to help meet the individual dosing needs of your hypothyroid patients1
Encourage Your Patients to Ask for the Thyroid-Shaped Pill
Educate patients on how to recognize their pill by its:
- Unique shape
- Dosage strength